Washington Biotechnology
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
      • Acute Choleostasis Model
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
      • WBI Cell Lines for Cancer Models
      • Xenograft, Orthotopic & Syngeneic Models
    • Bacterial Infection
      • MRSA Model
      • Listeria Model
    • Pain Studies
      • Formalin Test (Chemical Sensitivity)
    • Pharmacokinetics and Toxicity
      • Pharmacokinetics (PK)
      • Toxicity and MTD Studies
    • Support Services
      • In Vitro Compound Screening for Anti-inflammatory Activity
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers

About Us

 

Company Overview

Established in August 1988, Washington Biotechnology, Inc. (WBI) is located in Baltimore, Maryland, USA.

WBI’s major service areas are:

  • In Vivo Efficacy Testing of compounds and biologics over a wide range of disease models including inflammatory/autoimmune diseases and cancer.
  • Vaccine testing services including vaccine efficacy testing in disease model studies such as arthritis.
  • Bacterial efficacy studies in mice and rats to determine antibiotic efficacy.
  • Support Services including Pharmacokinetics, Toxicity, Pain Studies and Necropsy.

 

Registration and Accreditation:

U.S. Department of Agriculture (USDA)  Registration No. 51-R-031

Office for Laboratory Animal Welfare (OLAW) Animal Welfare Assurance Statement A4192-01

AAALAC accredited

Leadership

Sean O'Neill, PhD, MBA
Founder, President and Director of Operations

Dr. O'Neill is the Founder, President and Director of Operations for Washington Biotechnology, Inc.

Prior to founding WBI, Dr. O'Neill was Vice President of Immunodiagnostics for Pharmacia Diagnostics, Columbia, MD. Previous positions held with Electro-Nucleonics/ Pharmacia Diagnostics included Director of Product Development, Director of Manufacturing and Research & Development, and General Manager of Immunodiagnostics. Dr. O'Neill led the development and licensing of major diagnostic tests for AIDS and hepatitis and has over 100 publications in enzyme catalysis, immunology and immunodiagnostics.

Dr. O'Neill holds a PhD in Chemistry from the University of Toronto and an MBA from the American University, Washington D.C.

Contact Us
Request a Quote
What's New?
Read Our Newsletter

© Washington Biotechnology Inc., 2014. All Rights Reserved.
Built by Biz-Zone